Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 7 (MTND3P7) is a pseudogene annotated within the human genome that shares sequence similarity to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 (MT-ND3), which is a functional gene on mitochondrial DNA. However, as a pseudogene, MTND3P7 does not encode a functional protein and is not implicated as a therapeutic target or biomarker. The functional MT-ND3 gene plays a critical role in mitochondrial electron transport and oxidative phosphorylation, and pathogenic variants of MT-ND3 are linked to mitochondrial disorders such as Leigh syndrome and Leber hereditary optic neuropathy[1][2][3][4]. There are currently no studies, drugs, or disease associations directed at MTND3P7, distinguishing it from its functional counterpart. MTND3P7 must not be confused with MT-ND3, which is a well-characterized therapeutic and diagnostic target due to its role in mitochondrial bioenergetics and disease. Pseudogenes such as MTND3P7 may have regulatory or evolutionary significance, but no such functions have been identified or validated for this locus[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 7 (MTND3P7).